GPs ‘could do more’ to help obese avoid surgery
Although irritable bowel syndrome (IBS) is the most common disease diagnosed by gastroenterologists, it’s also one of the most misunderstood. That’s why updated guidelines addressing the management of the condition are being released by the American College of Gastroenterology. Through a comprehensive review of the latest medical research and expert consensus, the updated guidelines provide
Full Post: Updated guidelines for irritable bowel syndrome
Surgery to treat obesity could be avoided if GPs and healthcare trusts put more time and money into early stage weight management programmes, a senior clinical researcher will say today (Wednesday, 17 December, 2008).
And he will say that patients suffering from obesity face a “post code lottery” when seeking access to specialist care.
Speaking at the British Pharmacological Society’s Winter Meeting in Brighton today, Dr Nick Finer, Clinical Director, Wellcome Clinical Research Facility at Addenbrooke’s Hospital in Cambridge, will call for anti-obesity drugs to be more widely used.
Dr Finer will say that these drugs are cost-effective interventions and do work if correctly used.
But he will add that in some patients early potential for drug treatment to prevent the later need for surgery is being missed - due to the reluctance of primary care doctors to treat obesity.
In his presentation, entitled ‘Clinical challenges: can current drugs compete with surgery?’, Dr Finer will be discussing the place of drug treatment in the management of obesity.
Dr Finer said: “About one third of people taking the two drugs currently licensed for obesity management, in conjunction with a diet and lifestyle programme, will achieve a 10 per cent weight loss and around half a five per cent loss. Weight loss is well maintained if drug treatment is continued.
“Drug treatment has also been shown to delay or prevent the development of type 2 diabetes, reduce cardiovascular risk factors and improve well-being.
“These results clearly do not match surgery but could be more generally adopted in clinical care.
“Despite NICE (National Institute for Health and Clinical Excellence) guidelines, there is a reluctance of primary care doctors to treat obesity, with or without drugs, and thus the early potential for drug treatment to prevent the later need for surgery in some people is missed.
“There remains a strong antipathy from many doctors, primary care trusts and specialist commissioning groups to invest in obesity management.
“NICE guidelines - and even more seriously previous Health Technology Assessments - remain to be implemented. There is a complete post code lottery for patients to access specialist care.
“Until the QOF (Quality and Outcomes Framework) system remunerates GPs for undertaking weight management there will be little stimulus for adoption of current evidence-based treatment guidelines.”
Dr Finer is just one of the presenters at a special symposium on Obesity at the BPS Winter Meeting, which also includes a presentation on the regulatory challenges for new anti-obesity drugs. For the full programme please see below.
Face-to-face and telephone follow-up sessions appear to be more effective in the maintenance of weight loss for women from rural communities compared with weight loss education alone, according to a report in the November 24 issue of Archives of Internal Medicine. In addition, telephone counseling appears to be just as effective as face-to-to face counseling
Full Post: Telephone counseling may be as effective as face-to-face counseling in weight loss maintenance
A review of previously published studies suggests that rates of adverse outcomes for mothers or pregnant women and newborn babies, such as gestational diabetes and low birth weight, may be lower after bariatric surgery compared with pregnant women who are obese, according to an article in the November 19 issue of JAMA, the Journal of
Full Post: Risk of maternal and newborn complications may be lower after bariatric surgery
Globally every year, obese people waste billions of pounds on food products that ‘imply’ that they aid weight loss, but are totally ineffective, says a nutritional expert on bmj.com. Professor Lean from the University of Glasgow, is hopeful that a new European Union (EU) Directive on Unfair Commercial Practices, adopted this year in UK, will
Full Post: Millions being tricked into buying useless diet food products or supplements
A British nutrition expert says billions of dollars are being wasted on ‘quack’ health food products. According to Professor Michael Lean from the University of Glasgow, globally every year, obese people waste billions of pounds on food products that ‘imply’ that they aid weight loss, which are actually totally ineffective. Professor Lean says the distinction
Full Post: Expert says billions of dollars wasted on ‘quack’ health food products
Doctors are not doing enough to pick up on problems with excessive weight loss, says a Saint Louis University physician who helped draft recent guidelines to diagnose the condition called “cachexia” (kuh-kex-ee-uh). “In sick people, weight loss is an important indicator of disease and potentially impending death,” said John Morley, M.D., an endocrinologist and director
Full Post: Too much weight loss can be a bad thing